MAPK7 and neoplasm: IPA data indicated that the 19 mutations identified in this tumor were likely to involve proteins that contribute to ERK5 signaling (p = 0.049), PXR/RXR (p = 0.0521), and GPCR signaling (p = 0.0551) (Table 7).